Literature DB >> 1788163

Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration.

P Ashton1, S K Podder, V H Lee.   

Abstract

The objective of this study was to compare the influence of pH, tonicity, benzalkonium chloride, and EDTA on the conjunctival and corneal penetration of four beta blockers--atenolol, timolol, levobunolol, and betaxolol. Drug penetration was evaluated using the isolated pigmented rabbit conjunctiva and cornea in the modified Ussing chamber. The conjunctiva was more permeable than the cornea to all four beta blockers. Formulation changes caused larger changes in corneal than in conjunctival drug penetration, especially for the hydrophilic beta blockers, atenolol and timolol. Raising the solution pH to 8.4 caused the largest increase in corneal penetration for all drugs except atenolol. This increase was greater than that obtained by removing the corneal epithelium. The same formulation also increased conjunctival drug penetration, although to a lesser extent. In the case of timolol, the formulation changes evaluated brought about similar changes in its ocular and systemic absorption with good in vitro-in vivo correlations. The above findings indicate that in making formulation changes to maximize corneal drug penetration, it is necessary to evaluate possible changes in conjunctival drug penetration, hence systemic absorption. Moreover, because the conjunctiva plays an active role in the noncorneal route of ocular drug absorption, the relative contribution of the noncorneal to the corneal routes to ocular drug absorption may also be altered by formulation changes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788163     DOI: 10.1023/a:1015810619869

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  The normal surface of conjunctiva epithelium. A scanning electron microscopic study.

Authors:  R R Pfister
Journal:  Invest Ophthalmol       Date:  1975-04

2.  IN VITRO ION AND WATER MOVEMENT IN CORNEAS OF RAINBOW TROUT.

Authors:  H F EDELHAUSER; J R HOFFERT; P O FROMM
Journal:  Invest Ophthalmol       Date:  1965-06

3.  Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.

Authors:  J W Sieg; J R Robinson
Journal:  J Pharm Sci       Date:  1977-09       Impact factor: 3.534

4.  Demonstration of the mucous layer of the tear film by electron microscopy.

Authors:  B A Nichols; M L Chiappino; C R Dawson
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-04       Impact factor: 4.799

5.  Ocular ketone reductase distribution and its role in the metabolism of ocularly applied levobunolol in the pigmented rabbit.

Authors:  V H Lee; D S Chien; H Sasaki
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

6.  Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption.

Authors:  S C Chang; V H Lee
Journal:  J Ocul Pharmacol       Date:  1987

7.  Effects of calcium chelating agents on corneal permeability.

Authors:  G M Grass; R W Wood; J R Robinson
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-01       Impact factor: 4.799

8.  The tonicity of an eye drop and its dilution by tears.

Authors:  D M Maurice
Journal:  Exp Eye Res       Date:  1971-01       Impact factor: 3.467

9.  Penetration routes of topically applied eye medications.

Authors:  M G Doane; A D Jensen; C H Dohlman
Journal:  Am J Ophthalmol       Date:  1978-03       Impact factor: 5.258

10.  Comparison of conjunctival and corneal surface areas in rabbit and human.

Authors:  M A Watsky; M M Jablonski; H F Edelhauser
Journal:  Curr Eye Res       Date:  1988-05       Impact factor: 2.424

View more
  9 in total

1.  Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.

Authors:  Arthur Shedden; Ingrid A Adamsons; Albert J Getson; Jean K Laurence; Christopher R Lines; David J Hewitt; Tony W Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

2.  Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit.

Authors:  Y B Chung; K Han; A Nishiura; V H Lee
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

Review 3.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

4.  Hydrogels as Corneal Stroma Substitutes for In Vitro Evaluation of Drug Ocular Permeation.

Authors:  Susi Burgalassi; Erica Zucchetti; Leonardo Ling; Patrizia Chetoni; Silvia Tampucci; Daniela Monti
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

5.  Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery.

Authors:  L Marchal-Heussler; D Sirbat; M Hoffman; P Maincent
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

6.  Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.

Authors:  H Sasaki; Y Igarashi; T Nagano; K Nishida; J Nakamura
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

7.  A biodegradable ocular implant for long-term suppression of intraocular pressure.

Authors:  Xu Wen Ng; Kerh Lin Liu; Amutha Barathi Veluchamy; Nyein Chan Lwin; Tina T Wong; Subbu S Venkatraman
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

8.  A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy.

Authors:  Gloria Roberti; Lucia Tanga; Vincenzo Parisi; Massimo Sampalmieri; Marco Centofanti; Gianluca Manni
Journal:  Indian J Ophthalmol       Date:  2014-05       Impact factor: 1.848

9.  Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.

Authors:  Gen Suzuki; Eriko Kunikane; Keisuke Shinno; Seiko Kozai; Masaaki Kurata; Akio Kawamura
Journal:  Ophthalmol Ther       Date:  2020-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.